Exercise Augmentation of Exposure Therapy for PTSD: Rationale and Pilot Efficacy Data

Area of Science:

• Neuroscience
• Psychiatry
• Exercise Science

Background:

• Brain-derived neurotrophic factor (BDNF) is vital for synaptic plasticity, learning, and memory.
• Reduced BDNF is linked to anxiety disorders, cognitive deficits, and poorer treatment outcomes.
• Animal studies indicate exercise boosts BDNF and fear extinction, but human trials are lacking.

Purpose of the Study:

• To investigate the efficacy of combining prolonged exposure (PE) with exercise in treating posttraumatic stress disorder (PTSD).
• To determine if exercise augmentation enhances PTSD symptom improvement and BDNF levels.

Main Methods:

• A pilot study randomized 9 participants with PTSD into two groups: prolonged exposure alone (PE) or prolonged exposure plus exercise (PE+E).
• The PE+E group engaged in 30 minutes of moderate-intensity treadmill exercise before each PE session.
• BDNF levels and PTSD symptom severity were measured.

Main Results:

• The PE+E group demonstrated significantly greater improvement in PTSD symptoms compared to the PE-only group (d = 2.65).
• Elevated BDNF levels were observed in the PE+E group relative to the PE-only group (d = 1.08).

Conclusions:

• Exercise combined with prolonged exposure therapy shows promising results for PTSD treatment.
• This approach may enhance therapeutic outcomes by increasing BDNF levels.
• Further research is warranted to validate these findings in larger human trials.